Shuttle Pharma postpones special shareholder meeting
Shuttle Pharmaceuticals reschedules its special stockholder meeting to September 9, 2026, while keeping previously submitted proxies valid unless changed or revoked.
Rhea-AI Filing Summary
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has postponed its previously announced special meeting of stockholders from September 3, 2026, at 11:00 a.m. Eastern Time to September 9, 2026, at 11:00 a.m. Eastern Time, which will be the reconvened special meeting.
The company states that the postponement is to allow additional time to solicit proxies, give stockholders more time to consider the proposals and vote, and provide more time to consider an amendment to the terms of certain Milestone Events described in materials filed on September 1, 2026. Proxy votes must be received by 11:59 p.m. Eastern Time on September 8, 2026, and valid proxies already submitted will remain effective unless changed or revoked before votes are taken at the reconvened meeting.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Original special meeting date and time: September 3, 2026, at 11:00 a.m. Eastern Time
Reconvened special meeting date and time: September 9, 2026, at 11:00 a.m. Eastern Time
Proxy voting deadline: September 8, 2026, 11:59 p.m. Eastern Time
3 metrics
Original special meeting date and time
September 3, 2026, at 11:00 a.m. Eastern Time
Previously scheduled special meeting of stockholders
Reconvened special meeting date and time
September 9, 2026, at 11:00 a.m. Eastern Time
New date and time for the postponed special meeting
Proxy voting deadline
September 8, 2026, 11:59 p.m. Eastern Time
Deadline by which proxies must be received to be counted
Key Terms
special meeting of stockholders, Emerging growth company, Definitive Proxy Statement on Schedule 14A, Milestone Events
4 terms
special meeting of stockholders regulatory
"the postponement of its previously announced special meeting of stockholders"
A special meeting of stockholders is an unscheduled gathering called to let shareholders vote on specific, often urgent company decisions—like mergers, major asset sales, changes to the board, or amendments to governing rules. Think of it as an emergency town hall where owners cast ballots in person or by mail/online; outcomes can materially change a company’s strategy, control or value, so investors pay close attention and may need to vote or adjust holdings accordingly.
Emerging growth company regulatory
"Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Definitive Proxy Statement on Schedule 14A regulatory
"as disclosed in the Definitive Proxy Statement on Schedule 14A for the Annual Meeting"
Milestone Events financial
"consider the amendment to the terms of the Milestone Events described"
Milestone events are specific, agreed-upon checkpoints in a company’s plans or contracts — such as regulatory approval, product launch, or reaching a sales/clinical target — that mark meaningful progress. Investors watch them because they often trigger payments, change future revenue expectations or reduce uncertainty; think of them like signposts on a road trip that tell you how far the company has come and whether its prospects are likely to improve or stall.
FAQ
What change did SHPH announce about its special meeting of stockholders?
Shuttle Pharmaceuticals Holdings, Inc. postponed its special meeting from September 3, 2026, at 11:00 a.m. Eastern Time to September 9, 2026, at 11:00 a.m. Eastern Time, designating this as the reconvened special meeting.
Why is Shuttle Pharmaceuticals (SHPH) postponing the special meeting?
The company states it postponed the special meeting to allow more time to solicit proxies, give stockholders additional time to consider the proposals and vote, and allow additional time to consider an amendment to the terms of certain Milestone Events described in materials filed on September 1, 2026.
What is the proxy voting deadline for SHPH’s reconvened special meeting?
Proxy votes must be received by 11:59 p.m. Eastern Time on September 8, 2026 in order to be counted for Shuttle Pharmaceuticals Holdings, Inc.’s reconvened special meeting on September 9, 2026.
Are previously submitted proxies still valid for the SHPH reconvened special meeting?
Yes. Shuttle Pharmaceuticals states that valid proxies submitted prior to the original special meeting will remain valid for the reconvened special meeting, unless they are properly changed or revoked before votes are taken at the reconvened meeting.
How will stockholders be deemed present at the SHPH reconvened special meeting?
Stockholders will be deemed to be present in person and vote at the reconvened special meeting in the same manner described in the company’s Definitive Proxy Statement on Schedule 14A for the annual meeting, as supplemented and filed with the SEC on August 13, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
